Fingolimod Hydrochloride CAS 162359-56-0 Purity ≥99.0% (HPLC) API Factory High Purity

Short Description:

Chemical Name: Fingolimod Hydrochloride

CAS: 162359-56-0

Appearance: White to Off-White Powder

Purity: ≥99.0% (HPLC)

FDA approved drug for Multiple Sclerosis treatment.

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer with High Purity and Stable Quality
Chemical Name: Fingolimod Hydrochloride
CAS: 162359-56-0
Fingolimod Hydrochloride is a FDA approved drug for Multiple Sclerosis treatment.
API High Quality, Commercial Production

Chemical Properties:

Chemical Name	Fingolimod Hydrochloride
Synonyms	Fingolimod HCl; FTY 720
CAS Number	162359-56-0
CAT Number	RF-API39
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C19H34ClNO2
Molecular Weight	343.93
Melting Point	102.0~107.0°C
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Off-White Powder
Identification	HPLC
Melting Point	102.0~106.0℃
Solubility	Completely Soluble in Water
Purity / Analysis Method	≥99.0% (HPLC)
Moisture (K.F)	≤0.50%
Residue on Ignition	≤0.20%
Heavy Metals	≤20ppm
Residual Solvents
Dichloromethane	≤0.05%
Ethyl Acetate	≤0.50%
Ethanol	≤0.50%
Methanol	≤0.30%
Toluene	≤0.089%
THF	≤0.50%
DMF	≤0.088%
Relative Substances
Single Impurity	≤0.50%
Total Impurities	≤1.0%
Test Standard	Enterprise Standard
Usage	Active Pharmaceutical Ingredient (API)

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Fingolimod Hydrochloride (CAS: 162359-56-0) with high quality.
Fingolimod Hydrochloride is the first oral drug for the treatment of multiple sclerosis. It is successfully developed by the pharmaceutical company Novartis, and it has been approved for marketing by the US Food and Drug Administration (FDA). Multiple sclerosis is a debilitating neurological disease that can cause the patient to lose a sense of balance, appear muscle spasms and other movement disorders. Fingolimod Hydrochloride is a sphingosine-l-phosphate (S1PR) receptor modulator. After phosphorylation, It is bound to s1P receptor that is on the surface of lymphocyte, which will change lymphocyte migration, and promote cells into the lymphatic tissue, and prevent lymphocytes from leaving the lymphoid tissue and get into the graft. Thereby, it will prevent these cells from infiltrating the central nervous system (CNS), which achieves the effect of immunosuppression.